It was reported that after the completion of a transcarotid artery revascularization (tcar) procedure, the patient experienced contralateral weakness.The physician observed possible plaque prolapse on the angiogram imaging.Additional information stated that computed tomography angiography (cta) did not reveal any abnormalities, and the patient's symptoms improved and returned to baseline.At this time, the stroke etiology is unknown, and it is unclear if a p2y12 inhibitor test was performed.Based on this information, the reported event could be associated with the enroute transcarotid neuroprotection system (nps) and it will be reported out of an abundance of caution.
|
The product associated with this complaint was not returned to the manufacturer for analysis.A review of the manufacturing records for this device was completed and no issues were identified that could have led to the adverse event reported.There is no indication that a malfunction of the srm device occurred.At this time, it is unknown if the reported event is related to procedural issues, medication non-compliance or a silk road medical device failure, hence, the event will be reported out of abundance of caution.Complaints will continue to be reviewed and monitored for trends.All reasonably available information has been provided by the copan at the time of submission of this report.The fields that are blank are not an omission and indicate that the information is either not applicable or currently unavailable.If additional information is received, a supplemental report will be filed.
|